Related Experiment Video

Updated: Oct 11, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

RGS2 Suppresses Melanoma Growth via Inhibiting MAPK and AKT Signaling Pathways

Sheng-Jia Lin1, Yin-Cheng Huang1,2, Hao-Yuan Chen1

  • 1Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.

Anticancer Research
|December 1, 2021
PubMed
Abstract

Insights

Regulator of G protein signaling 2 (RGS2) inhibits melanoma cell growth by suppressing MAPK and AKT pathways. Its therapeutic potential is cell-dependent, requiring further investigation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Melanoma is an aggressive skin cancer.
  • Understanding regulators of melanoma cell growth is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of Regulator of G protein signaling 2 (RGS2) in regulating melanoma cell proliferation.
  • To explore the underlying molecular mechanisms involving MAPK and AKT pathways.

Main Methods:

  • Over-expression of RGS2 in human melanoma cell lines (A375, A2058) and mouse melanoma cells (B16F10).
  • Knockdown of Rgs2 in zebrafish embryos.
  • Analysis of MAPK and AKT signaling pathway activation.

Main Results:

  • RGS2 expression varied across melanoma cell lines.
  • RGS2 over-expression inhibited cell growth and suppressed MAPK/AKT activation in B16F10 cells.
  • RGS2 repressed AKT activation in A2058 cells and affected MAPK/AKT in zebrafish embryos, indicating context-dependent effects.

Conclusions:

  • RGS2 inhibits melanoma cell growth through MAPK and AKT pathways, but its efficacy is influenced by the cellular genetic context.
  • RGS2 warrants further research as a potential anti-melanoma therapeutic agent.
Keywords:
Rgs2/RGS2melanocytemelanomazebrafish

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.6K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K